Commercial & Institutional Reach

Zenvor Global operates secondary repackaging programmes for biosimilars, specialty injectables, and high-value generics through licensed, GMP-compliant free zone infrastructure in Panama. Bulk vials enter a bonded free zone facility duty-free, where cartonisation, leaflet insertion, labelling, and market-ready finishing are executed under controlled conditions.

The facility is purpose-built for pharmaceutical handling at scale — with multi-temperature storage, full cold chain continuity, and internationally certified quality systems governing every stage. WHO and EU GMP standards apply end-to-end, from receipt inspection through to pre-release quality sign-off.

The result is a meaningful reduction in landed cost — making products directly price-competitive against local manufacturers in both public tender and private channel distribution.

At Zenvor Global, we enable access to high-quality pharmaceutical products across retail channels by collaborating with established local partners who understand the pulse of their markets. Our territory-specific portfolio, backed by rigorous regulatory standards, ensures that essential therapies are present on pharmacy shelves where they’re needed most.

We work closely with sales and medical teams on the ground to help drive awareness, support prescription generation, and strengthen relationships with healthcare providers—ultimately enhancing patient access to trusted, effective treatments across key therapeutic areas.

We work with stakeholders across the pharmaceutical supply chain to meet the complex requirements of public healthcare procurement. From sourcing to final delivery, we align with institutional partners to ensure timely fulfilment of awarded quantities, adherence to regulatory standards, and consistency in supply.

By bridging global manufacturing capabilities with local market needs, we help streamline delivery schedules, reduce bottlenecks, and support the successful execution of national tenders and health initiatives—contributing to broader goals of access and reliability in essential care.